Avanti Biosciences is a private biotechnology company located in the JLABS incubator on the Johnson & Johnson Innovation Labs campus in San Diego.

We focus our research on the discovery and development of innovative therapies for patients with debilitating diseases. Our strategy is to develop efficient form of therapies designed to control complex diseases via new chemical entities (NCE) derived from natural products by making them more bio-available and selective. 

                 

Avanti's scientific founders are internationally recognized in the field of drug discovery and clinical development. They have exceptional track record in identifying and translating new research into breakthrough science and therapeutics.

                 

The scientific discoveries of Avanti Biosciences have also the potential for applications in a wide range of other therapeutic indications including pain, cancer, allergy, and inflammation.

At a Glance
  • Private R&D stage biotech company
  • Research focused on the treatment of unmet medical needs like:
    • Down Syndrome
    • Hyperinsulinemia Syndrome 
    • Alzheimer's Disease
    • Multiple Sclerosis
  • Technology based on natural catechins that are major components of green tea 
  • Research is funded through private funds and NIH grants